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Regarding "A case of  cystic adventitial disease of 
the popliteal artery demonstrated by magnetic 
resonance imaging" 
To the Editors: 
I read with interest he recent article by Crolla et al. 
(J VASC SURG 1993; 18:1052-5). In this article the authors 
recommend computed tomography (CT) or magnetic 
resonance imaging (MRI) as the diagnostic tool of choice 
in young patients who are free of atherosclerosis and who 
have episodes of intermittent clandication of the calf. The 
authors present a case of cystic adventitial disease (CAD) 
demonstrated byMRI as a large intramural mass producing 
a slitlike compression of the arterial umen. 
We have recently reported two cases of CAD of the 
popliteal artery.1 In one case, MRI showed on T2-weighted 
images, a significant compression of the popliteal artery 
lumen by a surrounding mass, similar to Crolla's findings. 
We additionally were able to visualize a double communi- 
cation that entered the knee joint capsule. One of the 
connections reached the intercondylar space, whereas the 
other reached the serous bursa of the lateral head of 
gastrocnemious muscle. We believe that these findings are 
highly specific, preoperative, diagnostic signs for CAD and 
that arteriography and CT scanning bring no additional 
necessary information i  the worknp of patients with CAD. 
It is interesting to notice that, in Crolla's article, no 
direct sign of CAD was exhibited by Tl-weighted MRI. 
Like Crolla, we failed to demonstrate any direct sign of 
CAD by Tl-weighted MRI for our second patient, even in 
transverse images. We concluded that MRI should include 
T2-weighted and gradient-echo sequences with three- 
dimensional Fourier-transformed volumic sequences for 
each patient with suspected CAD. 
We don't believe that the narrowing of arterial umen 
on Tl-weighted lateral projection MRI of the knee is a 
specific sign of CAD. We believe that this sign can be 
present in a normal population or in a population with a 
true or a functional entrapment of the popliteal artery. 
Hyperextension of the knee, sometimes completed by 
active plantar dorsiflexion, can also produce movement 
artifacts. 
Magnetic resonance angiography may be a more 
interesting alternative. Our policy is to avoid use of contrast 
material in young patients with CAD or popliteal artery 
entrapment syndrome 2 and who typically are free of 
atherosclerosis. Duplex scanning is first performed to 
obtain hemodynamic and circulatory data. The failure of 
the technique in visualizing direct signs of CAD is frequent, 
and, as was the case with Crolla's patient, duplex scanning 
could not exhibit a preoperative diagnosis for our patients. 
However, duplex scanning is useful to detect parietal 
calcifications and atherosclerosis n older patients and 
should thus be used as a first-line diagnostic test. Then 
MRI, including T2-weighted MRI and magnetic resonance 
angiography, is performed and gives morphologic data 
about he cyst and possible communications with the knee 
joint. It also gives an arterial map that provides data 
comparable to angiography, particularly in young patients. 
The combination of these two techniques allows us to 
establish an early specific preoperative diagnosis and to 
avoid the use of contrast material and ionizing radiations. 
The cost of this noninvasive xploration is comparable to 
the association of duplex scanning, arteriography, and CT. 
The rarity of cystic adventitial disease of the popliteal artery 
and the potential for serious complications justify the only 
use of the most specific diagnostic test, that is, MRI 
associated with duplex scanning. 
Laurent Chiche, MD 
Department of Vascular Surgery 
HIA du Val de GrSce 
74 Bd Port-Royal 
75230 Paris Cedex 05, France 
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Importance of the occluded external carotid artery 
after carotid endarterectomy 
To the Editors: 
The interesting case report by Gaunt et al. (J VASC 
SURG 1994;20:104-7) documented an incipient hrombo- 
sis of the carotid artery detected in the operating room after 
carotid endarterectomy. Platelet-rich thrombus had formed 
on the raw endarterectomy surface, and no underlying 
technical error was apparent. An occlusion of the external 
carotid artery demonstrated byoperative angiography was 
corrected, and thrombectomy was performed. The authors 
concluded that there was no connection between the 
occluded external carotid artery and the thrombus forma- 
tion in the internal carotid artery. Although that conclusion 
may be entirely correct, I caution against he widely held 
concept that an occluded external carotid artery after 
carotid endarterectomy has no clinical significance. 
Although the occluded internal carotid artery stump 
has been widely recognized as a potential source for emboli 
through a patent external carotid artery system, scant, if 
any, attention has been directed toward the possibility of an 
occluded external carotid artery representing (1) a source of 
emboli through a widely patent internal carotid artery or 
(2) a focus for thrombosis involving the internal carotid 
artery. Rather, an occluded external carotid artery after 
carotid endarterectomy is generally viewed as having no 
clinical significance, and that is usually the case. 
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As an example of (1) above, a patient on whom I had 
performed bilateral carotid endarterectomies 8 years pre- 
viously was admitted with multiple episodes of amaurosis 
fugax in the eye appropriate o an occluded external carotid 
artery, although that internal carotid artery and the 
contralateral carotid system were widely patent on angiog- 
raphy. Operation consisted of endarterectomy and closure 
of the external carotid stump, which contained thrombotic 
material compatible with a source for emboli, with no 
subsequent episodes of visual or other neurologic difficul- 
ties. As an example of (2) above, a patient experienced a 
stroke 31/2 days after carotid endarterectomy associated 
with external carotid artery occlusion and extension o'f 
platelet-rich t rombus into the patent common carotid and 
internal carotid arteries, with embolization from it to the 
middle cerebral artery. 
An occluded external carotid artery after carotid 
endarterectomy ay represent a potential source for either 
chronic embolization or a site for extended thrombosis and 
embolization i  the acute situation. In the latter instance, 
it may he difficult to ascertain the relationship, if any, 
between thrombus in the occluded external carotid artery 
and thrombus in the common and internal carotid arteries. 
The fine case report, which documents a use for transcranial 
Doppler scanning, also calls attention to a potential 
problem from an acutely occluded external carotid artery. 
Robert L. Hew#t, MD 
Department of Surgery 
Tulane University School of Medicine 
1430 Tulane Ave. 
New Orleans, LA 70112 
24/41/62002 
Reply 
To the Editors: 
We thank Dr. Hewitt for his interest in our case report, 
and his point regarding the potential importance of 
thrombus occluding the external carotid artery (ECA) is 
well made. In our case, thrombus was found on the 
endarterectomy surface in the internal carotid artery (ICA) 
separate from the origin of the ECA. Thrombus was not 
found to extend from the ECA to the ICA, neither was 
thrombus projecting from the ECA into the ICA or 
common carotid artery. Therefore we concluded that 
thrombus had formed at the two sites independently. 
However, the main point of our article was to highlight 
the ability of transcranial Doppler monitoring to provide 
direct evidence of particulate mbolization to the territory 
of the middle cerebral artery from whatever source. The 
original site of thrornbus formation may not be as 
important as the fact that the thrombus gives rise to 
significant embolization or results in a critical reduction in 
middle cerebral artery blood flow. Transcranial Doppler 
monitoring provides the surgeon with real-time vidence of 
both these parameters, enabling early reexploration of the 
artery, correction of the defect, and therefore the potential 
for preventing or minimizing neurologic deficits from this 
infrequent but often serious postoperative complication. 
Michael E. Gaunt, FRCS 
Department of Surgery 
Clinical Sciences Building 
Leicester Royal Infirmary 
Leicester LE2 7LX, United Kingdom 
24/41/62003 
Clinical trials a must 
To the Editors: 
The year 1991 was a landmark in vascular surgery. The 
North American Symptomatic Carotid Endarterectomy 
Trial (NASCET) 1 and the European Carotid Surgery Trial 
(ECST) 2 were completed and yielded clear evidence that 
carotid endarterectomy was the optimal treatment in 
patients with symptoms of carotid artery stenosis of 70% 
or greater of arterial diameter. Now, the news of the early 
completion of the Asymptomatic Carotid Atherosclerosis 
Study (ACAS) heralds another advance in our understand- 
ing of carotid artery disease. But even more important than 
the results of these trials is the fact that randomized, 
prospective, multicenter t ials were applied to a vascular 
surgical problem. Never before has such an approach to a 
vascular disorder been undertaken. 
The truth of the matter is that in the field of vascular 
surgery, investigation by clinical trials has lagged far 
behind other surgical subspeciakies. In particular, surgical 
oncologists have championed the clinical trial for decades. 
From the early trials of lumpectomy versus radical mas- 
tectomy 3 to the present day trials of cancer immnno- 
therapy, oncologists have long understood the power of 
the clinical trial. It is time for the vascular community 
to follow suit. 
For the most part, the NASCET, ECST, and ACAS 
trials have concluded. Now is not the time for con- 
gratulating one another on a job well done. It is the time 
to take the momentum gained from these recent rials and 
to apply it to the many unanswered questions currently 
plaguing vascular surgery. As an example, one specific area 
that bears immediate investigation comes to mind. Re- 
cently, use of the "Taylor" anastomotic vein patch has 
become widespread. 4 Although I do not dispute the 
results of Taylor, s they represent a single-center and, for 
the most part, a single-surgeon experience. Although 
polytetrafluoroethylene with an anastomotic vein patch 
may be a useful adjunct to the more commonly used 
vascular conduits, the need for a multicenter trial is 
obvious. The application of this technique by the surgical 
community with expectations of a conduit panacea, how- 
ever, only reinforces the commonly held view of vascular 
surgery as an anecdotal science. A clinical trial exploring 
the utility of such a novel and attractive conduit would 
require only a fraction of the effort involved in organizing 
the carotid artery trials. Although this is a single example, 
I dare say it would take little time to sight several more 
